A carregar...

A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion

Background. Proper diagnosis of pancreatic lesion etiology is a challenging clinical dilemma. Studies suggest that surgery for suspected pancreatic ductal adenocarcinoma (PDAC) reveals a benign lesion in 5% to 13% of cases. The aim of our study was to assess whether routinely used biomarkers such as...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Piotr Hogendorf, Aleksander Skulimowski, Adam Durczyński, Anna Kumor, Grażyna Poznańska, Aleksandra Oleśna, Joanna Rut, Janusz Strzelczyk
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Limited 2017-01-01
Colecção:Disease Markers
Acesso em linha:http://dx.doi.org/10.1155/2017/8629712
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!